Echo Therapeutics Streamlines Cost Structure, Aiming At Critical Milestones

Echo Therapeutics, Inc., a company developing its non-invasive Symphony® CGM System as a needle-free, wireless continuous glucose monitoring system, has issued a mid-year update to its shareholders outlining the progress it has made this year, its upcoming key strategic priorities and milestones, and its efforts to conserve cash.

Echo Therapeutics Provides Mid-Year Update to Shareholders (via PR Newswire)

Company Streamlines Cost Structure with Focus on Achieving Critical Milestones Download image Echo Therapeutics, Inc. logo. (PRNewsFoto/Echo Therapeutics, Inc.) PHILADELPHIA, July 3, 2013 /PRNewswire/ — Echo Therapeutics, Inc. (Nasdaq: ECTE), a company…

published: July 3, 2013 in: Financial, News

Most read

Latest

^